Cargando…
Repeatability of hypoxia PET imaging using [(18)F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial
PURPOSE: Hypoxia is an important factor influencing tumor progression and treatment efficacy. The aim of this study was to investigate the repeatability of hypoxia PET imaging with [(18)F]HX4 in patients with head and neck and lung cancer. METHODS: Nine patients with lung cancer and ten with head an...
Autores principales: | Zegers, Catharina M. L., van Elmpt, Wouter, Szardenings, Katrin, Kolb, Hartmuth, Waxman, Alan, Subramaniam, Rathan M., Moon, Dae Hyuk, Brunetti, Jacqueline C., Srinivas, Shyam M., Lambin, Philippe, Chien, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589564/ https://www.ncbi.nlm.nih.gov/pubmed/26136164 http://dx.doi.org/10.1007/s00259-015-3100-z |
Ejemplares similares
-
Evaluation of tumour hypoxia during radiotherapy using [(18)F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
por: Zegers, Catharina M. L., et al.
Publicado: (2016) -
Pharmacokinetic modeling of a novel hypoxia PET tracer [(18)F]HX4 in patients with non-small cell lung cancer
por: Verwer, E. E., et al.
Publicado: (2016) -
Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020) -
[(18)F]-HX4 PET/CT hypoxia in patients with squamous cell carcinoma of the head and neck treated with chemoradiotherapy: Prognostic results from two prospective trials
por: Sanduleanu, Sebastian, et al.
Publicado: (2020) -
Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion
por: van Elmpt, Wouter, et al.
Publicado: (2015)